Arizona Pharmacy Flash
Dec. 4, 2012

Standards for patient-friendly container labels released
American Society of Health-System Pharmacists
The United States Pharmacopeial Convention recently unveiled universal standards for prescription drug container labels that are intended to make it easier for patients to take their medications as prescribed. The standards emphasize patient-friendly elements such as prominent placement of the most important information and the use of clear, simplified language and explicit instructions. The standards also address legibility by requiring high-contrast print, a large font size for critical information and prudent use of white space. More

Register today for the AzPA Psychiatric Certificate Program
AzPA
Assessing, Monitoring, and Managing Patients with Psychiatric Disorders: Comprehensive Medication Therapy Management to Optimize Pharmaceutical Care Learn more.
More

Inaugural Southwest Pharmacy Symposium
AzPA
Become a Pharmacy A.C.E. — Advocate, Communicate, Educate. Saturday, Jan. 26, 2013. Learn more.
More

NCPA: Gallup Poll Finds Public Confidence in Pharmacists at Record High
AzPA
National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued a statement in response to the annual Gallup survey regarding professional honesty and ethics. More

Shop Amazon.com and support AzPA
AzPA
Will you be shopping online at Amazon.com this holiday season? Bookmark the AzPA Amazon Affiliates page and a portion of your purchases will be donated to AzPA.More

Holiday shopping is upon us
AzPA
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.





More

Not an AzPA member? Join today
AzPA
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry.More

Walgreens program employs pharmacists to reduce hospital readmissions
Pharmacy Times
Walgreens recently announced a new transition of care program featuring pharmacists in a key role that aims to reduce readmission rates along with overall healthcare costs, while improving patient health outcomes and medication adherence. The program, called WellTransitions, is being rolled out as hospitals face pressure to keep readmission rates for Medicare patients low or pay penalties, which went into effect on Oct. 1. As part of the program, Walgreens pharmacists work with hospital staff to oversee the medication regimens of discharged patients.More

Medication adherence increased by automated phone and mail notices
Medical News Today
Patients newly prescribed a cholesterol-lowering medication were more likely to pick it up from the pharmacy if they received automated phone and mail reminders, according to a study published in the Archives of Internal Medicine. This is one of a few published studies to examine strategies for reducing primary nonadherence, which occurs when patients do not pick up new prescriptions.More

Chronically ill kids more vulnerable to hospital medical errors
Pharmacy Times
Even after accounting for confounding variables such as disease severity and length of stay, pediatric inpatients with chronic conditions are significantly more likely to experience medical errors, according to the results of a study.More

North Dakota Pharmacy Board bans additional synthetic substances
The Bismarck Tribune
John Snyder is a big man who looks like he could hold his own in a brawl. But relating what happened when his 13-year-old daughter had a bad reaction to a synthetic drug in October almost brought him to tears in front of the North Dakota Board of Pharmacy. The board recently held a public meeting at the North Dakota State Capitol to hear testimony on whether it should add numerous substances being used as alternatives to drugs to a list of banned substances. The board unanimously accepted the proposed rules as presented by the North Dakota Attorney General's Office. The synthetic substances will be illegal as soon as the rules are published with the Legislative Council.More

Antidepressants may lead to fewer seizures in people with epilepsy
HealthDay News
Besides helping to boost mood, antidepressants may also reduce seizure frequency for people with epilepsy, a new study suggests. The study, to be presented at the annual meeting of the American Epilepsy Society in San Diego, included patients who were prescribed one of two types of antidepressants — selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. These types include drugs such as Celexa, Paxil, Prozac and Zoloft, among others.More

Increased mortality with digoxin in AF
Medscape News
The use of digoxin in patients with atrial fibrillation is being called into question, with the publication of a new study suggesting it is associated with a significant increase in all-cause mortality. The study, a propensity-adjusted analysis of the AFFIRM trial that controlled for multiple comorbidities, was published online on Nov. 27 in the European Heart Journal. It found an overall 41 percent increase in all-cause mortality in patients taking digoxin versus those not taking digoxin. The increase in all-cause mortality was consistently observed in men and women and in patients with and without underlying heart failure. More

Common diabetes drug shows promise as ovarian cancer treatment
HealthDay News
Ovarian cancer may join a growing list of malignancies that seem to be slowed by a commonly prescribed diabetes drug. Ovarian cancer patients who were taking metformin at the time of their diagnosis survived longer than patients who weren't on the drug, a new study by Mayo Clinic researchers shows.More

Oral contraceptives may increase VTE risk in women with PCOS
Medscape News
Oral contraceptives, largely considered the most effective treatment to relieve symptoms for women with polycystic ovary syndrome, might place patients at elevated risk for venous thromboembolism events, according a population-based study. Risk for nonfatal VTE was two times greater among 43,506 women with a diagnosis of PCOS who were receiving combined hormonal contraceptives compared with 43,506 matched control women who were taking contraceptives but did not have PCOS. More